Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Update on the efficacy of rasburicase in the prevention of hyperuricemia in cancer patients

Feb. 14, 2005

Phase II data on the benefits of PT-141 in female sexual dysfunction

Feb. 14, 2005

Quark Biotech licenses BT-16 to Sanwa Kagaku Kenkyusho

Feb. 11, 2005

A phase II study shows effective glycemic control with Basulin in type 1 diabetes

Feb. 11, 2005

Benitec and Garven Institute to develop drugs for diabetes and obesity

Feb. 11, 2005

Dosing begins in first phase I study for obesity compound oleoyl estrone

Feb. 11, 2005

Japan Tobacco discloses calcium-sensing receptor antagonists for osteoporosis

Feb. 10, 2005

Zydus Cadila files IND in India for ZY-H1

Feb. 10, 2005

Diosynth and Pharming sign manufacturing agreement for rhC1INH

Feb. 10, 2005

Delay to Preos NDA submission

Feb. 10, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...